Zanamivir

Zanamivir is an antiviral medication used to treat and prevent influenza A and influenza B (flu). It is sold under the brand name Relenza and is available as an inhaler. It works by blocking the actions of the influenza virus in the body. It is usually taken as a single dose and is most effective when taken within 48 hours of the onset of flu symptoms. Side effects may include throat irritation, cough, and headache.

Zanamivir itself is the medication, and "Zanamivir inhalation" refers to the way it's delivered into the body. Here's a more detailed description of Zanamivir:

Type of medication: Zanamivir is an antiviral medication belonging to a class of drugs called neuraminidase inhibitors.

What it does: It targets the influenza virus (the flu virus) specifically by inhibiting an enzyme called neuraminidase. This enzyme helps the virus spread and infect healthy cells. By blocking neuraminidase, Zanamivir prevents the virus from multiplying and spreading, thereby shortening the duration and severity of flu symptoms.

Uses:

  • Treatment: Zanamivir inhalation is most effective when taken within two days of experiencing flu symptoms. It can help shorten the duration of flu symptoms by about 1-2 days.
  • Prevention: Zanamavir can also be used to prevent the flu if you've been exposed to someone who has it or during a flu outbreak in your community.

Dosage and Administration:

  • Zanamivir comes as a powder in a single-use inhaler.
  • The specific dosage and duration of treatment will depend on whether you're using it for treatment or prevention and your age. It's crucial to follow your doctor's instructions exactly.
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AH Neuraminidase inhibitors
External Links